IMR Press / RCM / Special Issues / transcatheter_aortic_valve_interventions

Clinical Outcomes and Prognosis of Transcatheter Aortic Valve Interventions

Submission deadline: 15 October 2023
Special Issue Editors
  • Elmar W. Kuhn, MD, PhD
    Department of Cardiothoracic Surgery, University of Cologne, Cologne, Germany
    Interests: cardiac surgery; interventional cardiology; heart valve disease; coronary artery disease; heart failure; heart team approach; healthcare management
  • Matti Adam, MD, PhD
    Department of Cardiology, University Hospital Cologne, Kerpener Str. 62, Cologne, Germany
    Interests: structural heart disease/TAVR; interventional cardiology; heart failure; pacemaker/ICD; innate immunity
Special Issue Information

Dear Colleagues,

The advent of transcatheter aortic valve implantation has fundamentally changed the management of heart valve disease. In addition to surgical aortic valve replacement, it has added another option for the treatment of patients presenting especially with aortic valve stenosis. Initial studies have investigated the value of transcatheter techniques in patients with prohibitive and very high risk for conventional surgery and have documented favorable outcomes compared to standard treatment. Transcatheter aortic valve implantation has broadened the spectrum of patients suitable for the treatment of aortic valve stenosis with subsequent trials comparing surgical and interventional treatment options in patients with lower risk profiles showing promising results for the less-invasive catheter-based approach. Besides patients presenting with aortic valve stenosis, transcatheter techniques were refined for patients with bicuspid aortic valve pathologies, aortic valve insufficiency, and ultimately endocarditis. Furthermore, a growing body of evidence shows encouraging results regarding the long-term durability of transcatheter aortic valve prostheses.

During the past decades, the surgical approach for the treatment of aortic valve pathologies was basically challenged putting initial postoperative results and long-term outcomes into question. Less-invasive transcatheter techniques are about to replace the conventional treatment as the gold standard for certain indications. Pros and cons for both treatment options need to be analyzed in a well-balanced manner and guideline recommendations must be adjusted in the light of current results for the different subsets of patient cohorts. Both, the analysis and the adjustment should incorporate all members of the heart team with prime consideration being the benefit for the patient.

Dr. Elmar W. Kuhn and Dr. Matti Adam

Guest Editors

Keywords
aortic valve disease (stenosis/insufficiency)
transcatheter aortic valve implantation/replacement
surgical aortic valve replacement
short-/long-term outcomes
bicuspid aortic valve
endocarditis
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.

Published Paper (5 Papers)
Back to top